ABTERRA BIOSCIENCES, INC.
Machine learning algorithms for de novo antibody discovery from polyclonal antibody protein samples using mass spectrometry data
- Sector
- Biotech
- Headquarters
- San Diego, CA
- Total capital
- $9M
- Federal grants
- $8.5M
- 13 awards · 2017–2025
- Rank in peer group#3 of 19
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $556K
- 2 awards · Health and Human S
- Rank in Biotech#224 of 4373
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · REPTOR: accelerating antibody discovery and improving hits with machine learning$961K
- Federal grantHealth and Human S · Phase II · REPTOR: accelerating antibody discovery and improving hits with machine learning$64K
- Federal grantHealth and Human S · Phase II · REPTOR: accelerating antibody discovery and improving hits with machine learning$856K
- Federal grantHealth and Human S · Phase II · Alicanto: Proteogenomic discovery of single chain antibodies in llama$492K
- Federal grantHealth and Human S · Phase II · Software for sequencing human antibody proteins from polyclonal immune responses$749K
- Federal grantHealth and Human S · Phase II · Quorum: glycopeptide discovery via mass spectrometry and spectral networking$675K
- Federal grantHealth and Human S · Phase II · Quorum: glycopeptide discovery via mass spectrometry and spectral networking$551K
Show 8 earlier federal awards
- Federal contractHealth and Human S · Laboratory And Testing Services$15K
- Federal grantHealth and Human S · Phase II · Software for sequencing human antibody proteins from polyclonal immune responses$1.6M
- Federal grantHealth and Human S · Phase I · Intelligent in silico antibody library design and optimization for therapeutic use$244K
- Federal grantHealth and Human S · Phase II · Alicanto: Proteogenomic discovery of single chain antibodies in llama$1.1M
- Federal contractHealth and Human S · Comprehensive Reagents For Immunophenotyping Rabbit Cell-mediated Immunity.$541K
- Federal grantHealth and Human S · Phase I · Alicanto:Proteogenomic discovery of single chain antibodies in llama$170K
- Federal grantHealth and Human S · Phase I · Quorum:natural product discovery via mass spectrometry and molecular networking$193K
- Federal grantHealth and Human S · Phase II · An integrated transcriptomic and proteomic approach to antibody sequencing and repertoire characterization$887K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 19 peers
Line = medianBiotech · Software
- Federal grants#3 · top 16%
- Linked publications#2 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 3- PendingMethod For Antibody Identification From Protein MixturesUSPTOApplication 18481945
- PendingMethod For Antibody Identification From Protein MixturesUSPTOApplication PCTUS2022023627
- PendingMethod For Antibody Identification From Protein MixturesUSPTOApplication 63201056
Recent research by its founders
- Serum proteomics reveals high-affinity and convergent antibodies by tracking SARS-CoV-2 hybrid immunity to emerging variants of concern20250 cites
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases20250 cites
- Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases20242 cites
Related companies, and why
- Protein Innovation Labs, Inc.Similar federal contract value in Biotech · $586K in contracts
- MOLECULAR TARGETING TECHNOLOGIES, INC.Similar federal contract value in Biotech · $573K in contracts
- TERA-PRINT LLCSimilar federal contract value in Biotech · $569K in contracts
- ALLELE BIOTECHNOLOGY AND PHARMACEUTICALSSimilar federal contract value in Biotech · $550K in contracts
- VITAN-BIOTECH LLCSimilar federal contract value in Biotech · $550K in contracts
- Oleolive, Inc.Similar federal contract value in Biotech · $550K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .